Pancreatic and Biliary Stents Market

Global Pancreatic and Biliary Stents Market: Snapshot

Endoscopic stenting has shown a large therapeutic potential in the management of a range of pancreatico-biliary diseases. This also includes treatment of bilio-pancreatic leakages and prevention of post- endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. The endoscopic stenting market has drawn strength from continuous advances in therapeutic endoscopy, especially with respect to the device design and insertion techniques. Several technological advancements in pancreatic and biliary stents have enabled clinicians in providing lumen-to-lumen anchoring and reduce bilio-pancreatic leakages. Lumen-apposing metal stents have thus gathered steam for managing benign as well as malignant conditions in the pancreatic and biliary stents market.

The use of pancreatic and biliary stents as interventional treatment in pancreatic cancer is relatively new development in the market. Stridently, the paradigm of palliative stent therapy is fast evolving. In this regard, self-expanding metal stents are implanted for almost all palliative care. Growing population of patients with chronic pancreatitis are good candidates of pancreatic ductal stent implantation. Over the past few years, endoscopists have updated themselves with new techniques of endosonography and self-expanding metal stents so as to expand the applications of pancreatic and biliary stents.

Global Pancreatic and Biliary Stents Market: Notable Developments

Top players in the pancreatic and biliary stents market are stridently focused on launching new products with advanced stenting technology. The market has been witnessing trend of oligopolistic competition and fair degree of fragmentation of shares among a handful of well-entrenched players. Top players despite their stronghold should strive for new revenue streams to consolidate their positions in the pancreatic and biliary stents market. A large portion of the sales revenue is expected to come from ambulatory care centres and cancer care centres.

Numerous stent manufacturers are aiming at emerging market, such as that of Asia Pacific, in addition to expanding their product portfolio in developed markets. These manufacturers have also benefitted from favorable results from studies evaluating the performance of self-expanding metal stents. Top players operating in the pancreatic and biliary stents are:

• Abbott Laboratories
• Becton, Dickinson and Company
• ENDO-FLEX GmbH
• Taewoong Medical Co., Ltd.
• Medtronic Plc.
• Olympus Corporation
• CONMED Corporation

Global Pancreatic and Biliary Stents Market: Growth Dynamics

Fast evolving relevance of palliative therapy in pancreatic cancer is a key factor driving the demand for pancreatic and biliary stents. Over the years, life expectancy of patients with unresectable pancreatic cancer has increased, which in turn bolstered the prospects of the pancreatic and biliary stents market. Growing use of these stents in applications of self-expanding metal stents (SEMS) and endosonography is boosting the pancreatic and biliary stents market. In particular, the use of pancreatic stents for treatment for pain in chronic pancreatitis has gathered traction.

Growing numbers of patients with resectable pancreatic cancers undergoing neoadjuvant therapy have expanded the case of pancreatic stenting. The patient cohort is a major candidate for preoperative biliary stenting. In this regard, the safety of SEMS for biliary drainage is also a promising trend the pancreatic and biliary stents market. In recent years, they have also shown marked efficacy. The market has also benefitted from clinicians adoption of minimally invasive transpapillary approach.

Global Pancreatic and Biliary Stents Market: Regional Analysis

From the regional standpoint, developing economies are presenting lucrative opportunities and emerging at faster pace than most developed regions of the world. A part of this may be attributed to growing number of research and development avenues by medical device manufacturers, especially in Asia Pacific. North America and Europe are expected to be key lucrative markets in the years to come. Over the past five years, numerous randomized controlled trials have been done in the U.S. This has presented considerable research venues for players in the North America.